What Is CBG and What Does the Research Actually Show?
Cannabigerol, or CBG, is one of more than 100 cannabinoids found in the cannabis plant. It does not cause a high. Right now, human research on CBG by itself is very limited, and no CBG product has FDA approval for treating any condition. Most of what companies say about CBG online is based on early lab and animal studies, not large human trials.
This article explains what CBG is, how scientists think it differs from CBD, and what the current research does and does not support. It also compares the evidence gap for CBG against the evidence gap for CBD, since CBD already has years of head start in research funding and public attention.
Before You Consider Any CBG Product
Do not use CBG, CBD, or any other cannabinoid product to delay seeing a doctor about a health problem. If you take prescription medication, are pregnant or breastfeeding, or have a liver condition, talk with a healthcare provider before trying any cannabinoid product, since cannabinoids as a class have been linked to drug interactions and liver-related effects in research on CBD specifically.
Where CBG Comes From
The cannabis plant contains hundreds of chemical compounds. Cannabinoids are one group within that larger chemical family. The two most studied cannabinoids are THC and CBD. Beyond those two, federal health researchers note that more than 100 other cannabinoids have been identified, and CBG is one of them.
Cannabis chemistry literature commonly describes CBG’s acidic form, CBGA, as an early compound in the plant’s own production process, since plant enzymes convert it into the acidic forms of THC, CBD, and other cannabinoids as the plant matures. This is a point about plant biochemistry, not a claim about health effects in people.
How CBG Differs From CBD
CBG and CBD are both non-intoxicating cannabinoids, meaning neither produces the “high” associated with THC. Beyond that similarity, the two compounds are pharmacologically distinct, and the research base behind them is very different in size.
- FDA-approved drug status: A purified form of CBD is the active ingredient in Epidiolex, an FDA-approved prescription drug for two rare seizure disorders. No CBG-based product has FDA approval for any condition.
- Volume of human research: Federal health researchers describe cannabinoid research beyond THC and CBD as still expanding. CBG has far fewer published human studies than CBD.
- Regulatory status as a supplement: The FDA has stated that products containing THC or CBD cannot legally be sold as dietary supplements. CBG comes from the same plant and falls under the same general cannabinoid framework, which raises similar regulatory questions.
What “Early-Stage Research” Means
When you see the phrase “early-stage research” attached to a compound, it usually means one or more of these things:
- Most existing studies were done in cells or animals, not in people
- Human studies that do exist are small, short, or not well controlled
- Findings have not been confirmed by independent, larger follow-up studies
- No health authority has reviewed the evidence and approved a specific health claim
This description fits CBG closely. Federal reviews of cannabis and cannabinoid research note that beyond THC and CBD, the wider group of more than 100 other cannabinoids, which includes CBG, remains far less studied in people.
CBD vs. CBG: Evidence Gap Comparison
The comparison below lays out the evidence gap in plain terms. It compares research status, not personal experiences or marketing claims.
CBD (More Researched)
- Has one FDA-approved prescription drug for two specific seizure disorders
- Has been examined in multiple systematic reviews of cannabinoids for chronic pain, with more limited human research specific to anxiety
- Documented side effects exist, including drug interactions and liver function changes observed in Epidiolex clinical studies
- Still not approved for over-the-counter health claims like anxiety or pain relief
CBG (Less Researched)
- No FDA-approved drug of any kind
- No large-scale, well-controlled human studies confirming specific health benefits
- Side effect and interaction data in humans is limited compared to CBD
- Marketing claims often run well ahead of the available published evidence
Why the Evidence Gap Is Wider for CBG Than CBD
CBD had a major head start. Once Epidiolex moved through clinical trials and FDA review, it attracted significant research funding and academic interest specifically toward CBD. CBG has not had that same pipeline. Federal fact sheet libraries that cover dietary supplement ingredients in detail do not currently include a dedicated CBG entry, reflecting how new and limited the formal research base remains.
This does not mean CBG is unsafe. It means there is not yet enough published human research to confirm specific benefits, typical side effects, or safe use in specific groups.
Extra-Caution Groups
Because human data on CBG specifically is limited, extra caution is reasonable for:
- People who are pregnant or breastfeeding
- Children and teenagers
- People taking prescription medications, since cannabinoids as a class have been linked to drug interactions
- People with liver conditions
- Anyone considering a CBG product as a substitute for a prescribed treatment
These are general precautions that apply to cannabinoid products as a category. A healthcare provider is the right source for guidance specific to your own health history and medications.
A Quick Label-Reading Checklist
- Look for third-party lab testing results, not just a claim of testing
- Check that the CBG amount per serving is clearly listed
- Confirm the product discloses THC content, since hemp-derived products can legally contain trace amounts
- Be skeptical of any label claiming to treat, cure, or prevent a disease
- Contact the manufacturer directly with questions about sourcing and testing
Frequently Asked Questions
Is CBG the same thing as CBD?
No. They are both non-intoxicating cannabinoids from the cannabis plant, but they are chemically distinct compounds with different research histories. CBD has an FDA-approved drug behind it. CBG does not.
Does CBG get you high?
No. Like CBD, CBG is considered non-intoxicating. THC is the cannabinoid responsible for the “high” associated with marijuana.
Is CBG legal?
Legal status depends on the source of the CBG, the amount of THC in the final product, and the laws of your specific state. The FDA has stated that certain cannabinoid products cannot legally be sold as dietary supplements at the federal level. Check current state and federal rules before purchasing.
Can CBG treat anxiety, pain, or inflammation?
There is not enough published human research to confirm that CBG treats any specific condition. Early lab and animal research has explored these areas, but that is not the same as proven results in people. Talk with a healthcare provider about treatment options for any diagnosed condition.
Educational Disclaimer
This article is for general education only. It does not diagnose any condition, recommend any treatment, or replace advice from a licensed healthcare provider. Cannabinoid research, including research on CBG, is still developing. Always talk with a qualified healthcare provider before starting, stopping, or changing any supplement or medication, and before using any cannabinoid product if you are pregnant, breastfeeding, managing a medical condition, or taking prescription drugs.
For more on how we verify claims on this site, see our Editorial Policy and our Medical Disclaimer. Some articles on this site reference products with which we have a commercial relationship; see our Affiliate Disclosure for details. For more foundational cannabinoid science content, visit our Cannabis and Cannabinoid Science section.
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.